/Investor DB

InFocus Capital Partners, LLC

Venture capital

Jericho · Seed–Series A · 18 people tracked

Also known as InFocus

Find your way into InFocus Capital Partners, LLC

Each arrow is one introduction. Sign up to fill in the first one.

18 people can intro you to Ron

Ask Ketan Yerneni to introduce you to Ron Weiss

You →Ketan · together at Northwestern University - The Feinberg School of Medicine →Ron

16 people can intro you to Rob

Ask Jamie Chen to introduce you to Rob Rothman

You →Jamie · together at Trilogy Equity Partners →Rob

Sign up to find every way you can get introduced to InFocus Capital Partners, LLC

  • Your email: who you already know at InFocus Capital Partners, LLC, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the InFocus Capital Partners, LLC team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

InFocus Capital Partners specializes in sourcing, capitalizing, and developing disruptive life sciences opportunities with a specific focus on ophthalmic innovation. The firm combines real-world clinical ophthalmic expertise with venture investment experience, leveraging a partnership structure and deep coverage of the ophthalmology field to identify differentiated opportunities and improve the probability of successful returns.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
HQ
Jericho, New York, US
Instruments
Equity
Founded
2016
Tracked investments
6

Team · 18 people

from the firm's website & public directories
Aron Shapiro· Senior Vice President, Asset Development & Partnering, Ora, Inc.

Advisory board member and SVP of Asset Development & Partnering at Ora, Inc.

David L. Katz· Medical Advisor, PL Developments

Advisory board member serving as Medical Advisor at PL Developments.

Donald Fishbein· President, Evolve Therapeutics

Advisory board member and President of Evolve Therapeutics.

Jeffrey Smith· CEO & Chief Investment Officer, Starboard Value LP

Advisory board member and CEO and CIO of Starboard Value LP.

Jodi Luchs· Chief Science Advisor

InFocus Capital Partners Chief Science Advisor and Co-Medical Director of Eyevance Pharmaceuticals.

Matt Chapin· Senior Vice President, Asset Development & Partnering, Ora, Inc.

Advisory board member serving as SVP of Asset Development & Partnering at Ora, Inc.

Parag A. Majmudar· President & Chief Medical Officer, Chicago Cornea Consultants, Ltd.

Advisory board member and President and Chief Medical Officer of Chicago Cornea Consultants.

What they invest in

from 6 of 6 portfolio companies

Biotech ×3Healthtech ×3AI & Machine Learning ×2Data & Infrastructure ×2Medical Devices ×2Crypto & Web3 ×1

HQs:United States×4

Investments · 6 tracked

founders shown can be your intro path

By year:2022 · 22019 · 12018 · 14 dated

ONL Therapeuticsonltherapeutics.comin✓ verified

ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.

BiotechHealthtechMedical DevicesAnn Arbor, US

David Zacks(Co-Founder & Chief Scientific Officer)inDavid Esposito(Executive Officer, Director)inConstance Chang(Executive Officer)John K Freshley(Executive Officer, Director)inJeffrey A Jamison(Executive Officer)in

BoardAaron Fletcher(Director)in

Co-investorsExSight VenturesInvest MichiganNovartis Venture FundVisionary VenturesBios PartnersJohnson & Johnson Innovation – JJDC+3 more

Trefoil Therapeuticstrefoiltherapeutics.comin✓ verified

Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.

BiotechHealthtechMedical DevicesSan Diego, US

David Eveleth(Executive Officer, Director)inSchalon Newton(Executive Officer)in

BoardChristy Shaffer(Director)inRalph Bradshaw(Director)

Co-investorsExSight VenturesHatteras Venture PartnersSolasta VenturesAccess BiotechnologyBios PartnersCorrelation Ventures+1 more

2C Tech2ctechcorp.comDec 2019

HealthtechIrvine, US

JAMES TAYLOR(Executive Officer)IRVING ROBERT ARMSTRONG(Executive Officer)ROBERT SHIMIZU(Executive Officer)NARESH MANDAVA(Director)

BoardAKITERU FURUKAWA(Director)CLAUDE BENEDICT(Director)

Co-investorsExSight Ventures

Vanavana.org𝕏Nov 2022 · $11.9M

Vana is an open data infrastructure platform that enables individuals to control and manage the data they generate, with the ability to choose how it is used by AI systems.

AI & Machine LearningData & Infrastructure

Art Abal(Founder)

Co-investorsAbstract VenturesAlphaLab CapitalCaladanEarl Grey CapitalParadigmSCB 10X+9 more

Vanavana.xyz𝕏Dec 2022 · $11.9M

Vana provides open data infrastructure for AI that lets individuals control the data they create and choose how it is used.

AI & Machine LearningCrypto & Web3Data & Infrastructure

Art Abal(Founder)

Co-investorsBoxGroupFlori VenturesCoinbase VenturesDeFiance CapitalExSight VenturesGSR+8 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Camras Vision

Frequently asked questions

How many investments has InFocus Capital Partners, LLC made?
InFocus Capital Partners, LLC has 6 tracked investments.
What stage does InFocus Capital Partners, LLC invest at?
InFocus Capital Partners, LLC invests at the Seed, Series A stages.
What sectors does InFocus Capital Partners, LLC focus on?
InFocus Capital Partners, LLC focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is InFocus Capital Partners, LLC located?
InFocus Capital Partners, LLC is headquartered in Jericho, US.

Similar investors

Featured in lists